Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
CLASS ACTION NOTICE FOR ZETA: Kessler Topaz Meltzer & Check, LLP Reminds Zeta Global Holdings Corp. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Co
Important January 21, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Celsius Holdings, Inc. Investors of Securities Fraud Class Action Lawsuit